AEterna Zentaris Inc (NASDAQ:AEZS)

0.5211
Delayed Data
As of 12:23pm ET
 -0.0069 / -1.31%
Today’s Change
0.48
Today|||52-Week Range
1.54
-13.15%
Year-to-Date

Today’s Trading

Previous close0.53
Today’s open0.55
Day’s range0.52 - 0.55
Volume1,145,922
Average volume (3 months)2,238,884
Market cap$47.8M
Dividend yield--
Data as of 12:23pm ET, 05/06/2015

Growth & Valuation

Earnings growth (last year)-221.74%
Earnings growth (this year)-17.24%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-99.82%
P/E ratio--
Price/Sales3,196.60
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
--Protea Biosciences G...0.000.00%
IMUCImmunoCellular Thera...-0.00-0.97%
ABACAoxin Tianli Group I...-0.06-3.43%
BCLIBrainstorm Cell Ther...+0.05+1.37%
Data as of 12:23pm ET, 05/06/2015

Financials

Last reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$11.0K
Annual profit (last year)-$16.6M
Net profit margin-156,245.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David A. Dodd
Chief Financial Officer &
Senior Vice President
Dennis Turpin
Corporate headquarters
Québec, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers